MedTrace Logo

Functional Outcomes and Control Using Synchron BCI - Australia

NCT07533903 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-06-09

No results posted yet for this study

Summary

Functional Outcomes and Control Using Synchron BCI - Australia (FOCUS-AUS)

Conditions

  • Neurologic Disorder
  • Neurologic Diseases
  • MND (Motor Neurone DIsease)
  • Motor Neuron Disease
  • Motor Neuron Disease, Amyotrophic Lateral Sclerosis
  • Paralysis Arm
  • Paralysis

Interventions

DEVICE

Stentrode

The Stentrode is an endovascular electrode array that senses electrical signals from the sensorimotor cortices.

Sponsors & Collaborators

  • Synchron, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-22
Primary Completion
2027-03-31
Completion
2027-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07533903 on ClinicalTrials.gov